Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- Check2 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1.0%
- Check9 days agoChange DetectedThe page has removed a significant update regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025, while also deleting several past dates and a previous version number.SummaryDifference1%
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has updated the treatment criteria for metastatic NSCLC, specifying the duration of monitoring and response documentation, while also revising the version number of the document.SummaryDifference2%
- Check45 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check59 days agoChange DetectedThe page has updated the number of study locations from 45 to 44 and removed specific location details in Hattiesburg, Mississippi.SummaryDifference0.9%
Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.